C:\documents And Settings\spolina\desktop\labeling Response\famotidine For Oral Susp\structure.jpg (82462011 668a 4fbd 9653 48049901eacc 01)
Famotidine For Suspension
Product Images NDC 43386-500
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 43386-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Conainer Label (82462011 668a 4fbd 9653 48049901eacc 02)
Carton Label (82462011 668a 4fbd 9653 48049901eacc 03)
Famotidine is an oral suspension used for treating ulcers in the stomach and intestines. To be taken as per the instructions given in the package insert. The bottle is oversized to allow for shaking. Keep it tightly closed and store the dry powder and suspension between 15-30°C. Protect suspension from freezing and discard any unused suspension after 30 days. Famotidine oral suspension has inactive ingredients such as anhydrous citric acid, flavors, microcrystalline cellulose, carboxymethylcellulose sodium, confectioner’s sugar, xanthan gum, corn starch, colloidal silicon-dioxide, sodium benzoate, and methylparaben sodium. It has to be constituted to 50 mL, each 5 mL containing 40 mg famotidine. The oral suspension is Cherry-Banana-Mint flavored and must be shaken well before use. Not for Injection. The drug is Rx Only. Manufacturing and distribution details are also available on the packaging.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
